OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES OF SUBRETINAL FIBROSIS IN AGE-RELATED MACULAR DEGENERATION

Purpose: To report the imaging features of subretinal fibrosis secondary to exudative age-related macular degeneration (AMD) on optical coherence tomography angiography. Methods: All consecutive patients diagnosed with subretinal fibrosis complicating exudative AMD were imaged by color retinal photographs or multicolor imaging, fluorescein angiography, spectral domain optical coherence tomography, and optical coherence tomography angiography. Eyes with active exudative features observed during the last 6 months were compared with those without any sign of exudation >6 months. Results: Forty-nine eyes of 47 consecutive patients were included. A blood flow inside the fibrotic scar could be detected in 46 of 49 cases (93.8%). Three patterns of vascular networks could be distinguished, that were described as pruned vascular tree (26 of 49 eyes; 53.1%), tangled network (14 of 49; 28.6%), and/or vascular loop (25 of 49; 51.0%). Furthermore, 2 types of hyporeflective structures, large flow void, and/or dark halo were observed in 63% and in 65% of eyes, respectively. The observed patterns did not differ between eyes with active or inactive lesions. Conclusion: Optical coherence tomography angiography of subretinal fibrosis showed almost constantly a perfused, abnormal vascular network and collateral architectural changes in the outer retina and the choriocapillaris layer. These features were associated with both active and inactive fibrotic choroidal neovessels.

[1]  Mbbs Md FRCPath Donald N. Pritzker Vinay Kumar Robbins and Cotran pathologic basis of disease , 2015 .

[2]  L. Ellis,et al.  Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  Gabriel Coscas,et al.  Optical coherence tomography identification of occult choroidal neovascularization in age-related macular degeneration. , 2007, American journal of ophthalmology.

[4]  P. Rosenfeld,et al.  Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials. , 2011, Ophthalmology.

[5]  Susan Schneider,et al.  Ranibizumab versus verteporfin for neovascular age-related macular degeneration. , 2006, The New England journal of medicine.

[6]  R. Tadayoni,et al.  CAUSES OF UNSUCCESSFUL RANIBIZUMAB TREATMENT IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION IN CLINICAL SETTINGS , 2012, Retina.

[7]  Martin F. Kraus,et al.  Split-spectrum amplitude-decorrelation angiography with optical coherence tomography , 2012, Optics express.

[8]  Alan W. Stitt,et al.  Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy. , 2004, The American journal of pathology.

[9]  Phillip G Yuile,et al.  Age‐related macular degeneration: a leading cause of blindness , 1997, The Medical journal of Australia.

[10]  K. Sonoda,et al.  A Novel Platelet-Activating Factor Receptor Antagonist Inhibits Choroidal Neovascularization and Subretinal Fibrosis , 2013, PloS one.

[11]  U. Chakravarthy,et al.  ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Outcomes in Eyes With Poor Initial Vision , 2015, Retina.

[12]  T. Hisatomi,et al.  Establishment of a new animal model of focal subretinal fibrosis that resembles disciform lesion in advanced age-related macular degeneration. , 2011, Investigative ophthalmology & visual science.

[13]  H. Grossniklaus,et al.  Clinicopathologic correlations of surgically excised type 1 and type 2 submacular choroidal neovascular membranes. , 1998, American journal of ophthalmology.

[14]  David Huang Clinical Guide to Angio-OCT: Non Invasive, Dyeless OCT Angiography , 2014 .

[15]  W. Cui,et al.  Interleukin-6 receptor blockade suppresses subretinal fibrosis in a mouse model. , 2014, International journal of ophthalmology.

[16]  K Bailey Freund,et al.  Do We Need a New Classification for Choroidal Neovascularization in Age-Related Macular Degeneration? , 2010, Retina.

[17]  John C. Hwang,et al.  Development of subretinal fibrosis after anti-VEGF treatment in neovascular age-related macular degeneration. , 2011, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

[18]  C. Van Noorden,et al.  The role of CTGF in diabetic retinopathy. , 2015, Experimental eye research.

[19]  R. Spaide Optical Coherence Tomography Angiography Signs of Vascular Abnormalization With Antiangiogenic Therapy for Choroidal Neovascularization. , 2015, American journal of ophthalmology.

[20]  Martin F. Kraus,et al.  Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration. , 2014, Ophthalmology.

[21]  Jay S Duker,et al.  Spectral-domain optical coherence tomography angiography of choroidal neovascularization. , 2015, Ophthalmology.

[22]  P T de Jong,et al.  An international classification and grading system for age-related maculopathy and age-related macular degeneration , 1995 .

[23]  M. Larsen,et al.  Subfoveal fibrosis in eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumab. , 2013, American journal of ophthalmology.

[24]  T. Sjöblom,et al.  Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate. , 2004, Cancer research.

[25]  Richard F Spaide,et al.  Retinal vascular layers in macular telangiectasia type 2 imaged by optical coherence tomographic angiography. , 2015, JAMA ophthalmology.

[26]  N. Niles Pathologic Basis of Disease , 1974 .

[27]  P. Campochiaro,et al.  Regression of choroidal neovascularization results in macular atrophy in anti-vascular endothelial growth factor-treated eyes. , 2015, American journal of ophthalmology.

[28]  D. Brigstock,et al.  Connective tissue growth factor: what's in a name? , 2000, Molecular genetics and metabolism.